^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    MEBGEN™ BRAF Kit

    Company:
    JSR Life Sciences
    Type:
    Other Approval
    Related tests:

    Details

    Evidence
    News
    MEBGEN™ BRAF Kit was developed as a companion diagnostic for multiple anti-cancer agents in melanoma. The MEBGEN BRAF Kit is expected to be an important clinical diagnostic in guiding personalized medicine for patients with melanoma. Used for the detection of BRAF gene mutations (V600E or V600K) in DNA extracted from cancer tissue.
    Cancer:
    Melanoma
    Gene:
    BRAF (B-raf proto-oncogene)
    Drug:
    Braftovi (encorafenib), Mekinist (trametinib), Mektovi (binimetinib), Tafinlar (dabrafenib)
    Method:
    PCR